Feasibility for development of a liposome/LNP displaying an HIV ENV trimer protein and containing/incorporating an mrna
Active Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,885,384
Award facts
- Opportunity
-
- 75N93024R00035 Solicitation number
- Contract value 100% obligated
- $5,885,384.00 Current and potential, with all options
- Completion date 54% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27708, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Exercise an Option | $3,428,567 | |
| Original award | $2,456,817 |
About this award
The National Institute of Allergy and Infectious Diseases issued a delivery order to Duke University on August 31, 2024, with a ceiling value of $5.885 million, for feasibility development of a liposome/LNP displaying an HIV Env trimer protein and containing/incorporating mRNA, and for preclinical and translational vaccine development support for HIV and other candidate agents.
The order is issued under the parent indefinite delivery contract titled "Preclinical and Translational Vaccine Development for HIV and Other Candidate Agents." Place of performance is Durham, North Carolina. The order carries a cost-no-fee pricing structure with an ultimate completion date of August 27, 2028. No set-aside was used for this award.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 31, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $5,885,384 on 75N93024F00001.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93022D00003, an indefinite delivery contract, on Preclinical And Translational Vaccine Development For HIV And Other Candidate Agents.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award